Inflammation and elevation of C-reactive protein: Does magnesium play a key role?

Magnesium Research

Volumn 22, Issue 2, 2009, Pages 57-59

  King, Dana E ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

C reactive protein; Inflammation; Magnesium

Indexed keywords

ANIMALIA;

EID: 67650803035     PISSN: 09531424     EISSN: 19524021     Source Type: Journal    
DOI: 10.1684/mrh.2009.0161     Document Type: Article

References (25)

1. Kruse HD, Orent ER, McCallum EV. Studies on magnesium efficiency in animals. I. Symptomatology resulting from magnesium deprivation. J Biol Chem 1932; 96: 519-39.
2. Bloom S. Coronary arterial lesions in Mg-deficient hamsters. Magnesium 1985: 82-95.
3. Walsh RJ, Weglicki WB, Correa-de-Araujo R. Distribution of specific substance P binding sites in the heart and adjacent great vessels of the Wistar white rat. Cell Tissue Res 1996; 284: 495-500.
4. Maier JA, Malpuech-Brugere C, Zimowska W, Rayssigu- ier Y, Mazur A. Low magnesium promotes endothelial cell dysfunction: implications for atherosclerosis, inflammation and thrombosis. Biochim Biophys Acta 2004; 1689: 13-21.
5. Mazur A, Maier JA, Rock E, Gueux E, Nowacki W, Rays- siguier Y. Magnesium and the inflammatory response: potential physiopathological implications. Arch Bio- chem Biophys 2007; 458: 48-56.
6. Bussiere F, Gueux E, Rock E, Mazur A, Rayssiguier Y. Protective effect of calcium deficiency on the inflammatory response in magnesium-deficient rats. Eur J Nutr 2002; 41: 197-202.
7. Malpuech-Brugère C, Rock E, Astier C, Nowacki W, Mazur A, Rayssiguier Y. Exacerbated immune stress response during experimental magnesium deficiency results from abnormal cell calcium homeostasis. Life Sci 1998; 63: 1815-22.
8. Rosanoff A, Seelig MS. Comparison of mechanism and functional effects of magnesium and statin pharmaceuticals. J Am Coll Nutr 2004; 23: 501S-505S.
9. Nassir F, Mazur A, Giannoni F, Gueux E, Davidson NO, Rayssiguier Y. Magnesium deficiency modulates hepatic lipogenesis and apolipoprotein gene expression in the rat. Biochim Biophys Acta 1995; 1257: 125-32.
10. Staprans I, Pan XM, Rapp JH, Feingold KR. The role of dietary oxidized cholesterol and oxidized fatty acids in the development of atherosclerosis. Mol Nutr Food Res 2005; 49: 1075-82.
11. Gueux E, Azais-Braesco V, Bussiere L, Grolier P, Mazur A, Rayssiguier Y. Effect of magnesium deficiency on triacylglycerol-rich lipoprotein and tissue susceptibility to peroxidation in relation to vitamin E content. Br JNutr 1995; 74: 849-56.
12. Guerrero-Romero F, Rodriguez-Moran M. Low serum magnesium levels and metabolic syndrome. Acta Dia- betol 2002; 39: 209-13.
13. Song Y, Ridker PM, Manson JE, Cook NR, Buring JE, Liu S. Magnesium intake, C-reactive protein, and the prevalence of metabolic syndrome in middle-aged and older US women. Diabetes Care 2005; 28: 1438-44.
14. Barbagallo M, Dominguez LJ. Magnesium metabolism in type 2 diabetes mellitus, metabolic syndrome and insulin resistance. Arch Biochem Biophys 2007; 458: 40-7.
15. Guerrero-Romero F, Rodriguez-Moran M. Hypomagne- semia, oxidative stress, inflammation, and metabolic syndrome. Diabet Metab Res Rev 2006; 22: 471-6.
16. King DE, Mainous III AG, Geesey M, Woolson RF. Dietary magnesium and C-reactive protein levels. JACN 2005; 24: 166-71.
17. King DE, Mainous III AG, Geesey M, Egan BM, Reh- man S. Magnesium supplement intake and C-reactive protein levels in adults. Nutr Res 2006; 26: 193-6.
18. Pakfetrat M, Malekmakan L, Roozbeh J, Haghpanah S. Magnesium and its relationship to C-reactive protein among hemodialysis patients. Magnes Res 2008; 21: 167-70.
19. King DE, Buchanan T, Mainous AG, Pearson W. C- reactive protein and glycemic control in adults with diabetes. Diabetes Care 2003; 26: 1535-9.
20. Cummings DM, King DE, Mainous AG, Geesey ME. Combining serum biomarkers: the association of C- reactive protein, insulin sensitivity, and homocysteine with cardiovascular disease history in the general US population. Eur J Cardiovasc Prev Rehabil 2006; 13: 180-5.
21. Belin RJ, He K. Magnesium physiology and pathogenic mechanisms that contribute to the development of the metabolic syndrome. Magnes Res 2007; 20: 107-29.
22. Sales CH, Pedrosa Lde F. Magnesium and diabetes mellitus: their relation. Clin Nutr 2006; 25: 554-62.
23. Corica F, Corsonello A, Ientile R, et al. Serum ionized magnesium levels in relation to metabolic syndrome in type 2 diabetic patients. JAm Coll Nutr 2006; 25: 210-5.
24. King DE, Mainous AGIII, Geesey ME, Ellis T. Magnesium intake and serum C-reactive protein levels in children. Magnes Res 2007; 20: 32-6.
25. Rayssiguier Y, Gueux E, Nowacki W, Rock E, Mazur A. High fructose consumption combined with low dietary magnesium intake may increase the incidence of the metabolic syndrome by inducing inflammation. Magnes Res 2006; 19: 237-43.